These were included in the multivariate analysis, and BCVA at 12 months was found to be significantly associated with baseline BCVA (estimate 0.44, 95% CI [0.30; 0.58], p < 0.001), fluid localization (IRF ± SRF group, estimate −8.65, 95% CI [−13.64; −3.65], p < 0.001), and presence of fibrosis at baseline (estimate −11.48, 95% CI [−19.85; −3.12], p = 0.007). The gene discussed is SRF; the disease is fibrosis.